𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CD36, serves as a receptor for advanced glycation endproducts (AGE)

✍ Scribed by Nobutaka Ohgami; Ryoji Nagai; Mamoru Ikemoto; Hiroyuki Arai; Akira Miyazaki; Hideki Hakamata; Seikoh Horiuchi; Hitoshi Nakayama

Book ID
114343531
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
113 KB
Volume
16
Category
Article
ISSN
1056-8727

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Endogenous secretory receptor for advanc
Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma
✍ Akihiko Takeuchi; Yasuhiko Yamamoto; Koichi Tsuneyama; Chunmei Cheng; Hideto Yon πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 393 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Chondrosarcoma, the second most frequent primary malignant bone tumor, is classified into 3 grades according to histologic criteria of malignancy. However, a low‐grade lesion can be difficult to distinguish from a benign enchondroma, whereas some histologically low‐grade

Arguing for the motion: Yes, RAGE is a r
Arguing for the motion: Yes, RAGE is a receptor for advanced glycation endproducts
✍ Ravichandran Ramasamy; Shi Fang Yan; Ann Marie Schmidt πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 188 KB

## Abstract Advanced glycation endproducts (AGEs) are an heterogenous class of compounds formed by diverse stimuli, including hyperglycemia, oxidative stress, inflammation, renal failure, and innate aging. Recent evidence suggests that dietary sources of AGE may contribute to pathology. AGEs impart